DeepVerge continues to ramp up progress across business divisions
- DeepVerge's Modern Water division to be leading sponsor at Reuters IMPACT conference on climate change
- DeepVerge would see big upgrade if Microtox BT gets CE Mark, says broker
- DeepVerge wastewater Covid-19 detection technology successfully completes trials
Quick facts: DeepVerge PLC
Price: 26.5 GBX
Market Cap: £57.02 m
About the company
Deepverge is a vertically integrated business, collaborating technology platforms with partners in artificial intelligence, clinical research, water technologies, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.
How it is doing
Gerard Brandon, chief executive of DeepVerge, will also host a panel to discuss 'What's our water trying to tell us, a global perspective'.
“We see the impact of climate change, disease and industrial chemicals in our water,” said Brandon.
“Our objective is to work together with governments, municipal, industry bodies and companies to provide the latest equipment and upgrade existing installations to monitor water in real-time and to provide the translation service of what water is telling us about what is needed to help change the way in which we address water and wastewater for current and future health crises, and the health of the planet."
“With H1 2021 growth secured, as in previous years, second-half revenues of DeepVerge are expected to be a multiple of H1,” said chief executive Gerry Brandon.
The two companies are working together to provide real-time monitoring solutions to detect and identify contaminants in water and soil.
What the brokers say
Earlier, DeepVerge reported initial results from phase III clinical studies of the rapid Coronavirus (COVID-19) breath test showed it can deliver results in under 60 seconds.
Chief executive Gerard Brandon described the early data from the real-world assessment of the Microtox BT system as a “major milestone”.
What management says
Deepverge's Gerry Brandon (LON:DVRG) joins Proactive London's Katie Pilbeam to discuss the successful completion of field trials and an agreement with a third-party installer for its Microtox PD water contamination system to enable early detection of Coronavirus (COVID-19) hotspots.
Brandon explains how the system achieved real-time detection and transmission of data, specific to SARS-CoV-2 particles, in wastewater treatment plants at multiple sites.
He explains in detail what was involved with the trials, how the system works, why they did not disclose the locations of the live-data alert installations and why it is so important for fighting the COVID-19 pandemic.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...FOR OUR FULL DISCLAIMER CLICK HERE